-
Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug - certolizumab pegol (Cimzia) - can be considered for some people in England and Wales suffering with rheumatoid arthritis.
National Institute for Health and Clinical Excellence (Rheumatology) - Tue, 9 March 2010
http://www.nice.org.uk
-
Arthritis rates were higher in the United States vs Canada, according to the first study to directly compare the prevalence and risk factors for the condition between the 2 countries.
Medscape (Rheumatology) - Mon, 1 March 2010
http://www.medscape.com
-
Like other autoimmune diseases, including adult RA, risk of developing juvenile idiopathic arthritis (JIA) is thought to be determined by a complex combination of genetic and environmental factors.
Rheumatology (Rheumatology) - Mon, 1 March 2010
http://rheumatology.oxfordjournals.org/
-
Fibromyalgia patients who received cognitive behavioral therapy in a pilot study had a higher threshold for the nociceptive-flexion reflex, an objective measure of the transmission of potentially painful stimuli to the central nervous system.
Medscape (Rheumatology) - Fri, 12 February 2010
http://www.medscape.com
-
The eye has often been spoken of as the window to medicine. The expertise of rheumatologists in the use of immunosuppressant drugs, including biologic agents, in inflammatory diseases, is invaluable to many specialties, including ophthalmology.
Rheumatology (Rheumatology) - Fri, 12 February 2010
http://rheumatology.oxfordjournals.org/
-
A simple blood test may allow doctors to identify a debilitating form of arthritis years before any symptoms appear, which may help to stop the disease in its tracks, new research suggests.
CNN.com (Rheumatology) - Fri, 5 February 2010
http://www.cnn.com
-
Proteins in the blood may signal RA years before symptoms develop.
Medscape (Rheumatology) - Mon, 1 February 2010
http://www.medscape.com
-
Final draft guidance published today (Thursday 21st January 2010) by the National Institute for Health and Clinical Excellence (NICE) has enabled another therapy to be considered for some people in England, Wales and Northern Ireland suffering with rheumatoid arthritis. In the draft, certolizumab pegol is now recommended as a treatment option for some patients with the disease.
National Institute for Health and Clinical Excellence (Rheumatology) - Fri, 22 January 2010
http://www.nice.org.uk
-
When there is an acute arthritis, we know that the finding of a normal value of serum urate doesn’t cer-tainly exclude the presence of a gout attack. According to this consideration, some researchers won-dered which is the usual behaviour of serum urate during gout attacks and they have analyzed the data from two trials previously published and concerning anti-inflammatory therapies for gout attacks.
MedNews (Rheumatology) - Fri, 15 January 2010
http://mn.medsurfnews.com/
-
The title of this volume neatly summarizes its content. It is the printed version of the National Institute for Health and Clinical Excellence (NICE) clinical guideline 79.
Rheumatology (Rheumatology) - Fri, 15 January 2010
http://rheumatology.oxfordjournals.org/